Stocktoria
HYPERION DEFI, INC. HYPD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-01-25
HYPERION DEFI, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $813,455 | $57,336 | $3,787 | — | $14.0M |
| Gross profit | $510,165 | -$3.9M | -$12,218 | — | $12.4M |
| R&D expense | $1.9M | $14.5M | $13.0M | $13.4M | $14.9M |
| SG&A expense | $17.2M | $14.3M | $12.4M | — | — |
| Operating income | -$46.7M | -$48.7M | -$25.4M | -$26.9M | -$13.0M |
| Interest expense | — | — | $2.4M | $1.4M | $387,756 |
| Income tax | -$30,940 | — | — | — | — |
| Net income | -$45.3M | -$49.8M | -$27.3M | -$28.0M | -$12.8M |
| EPS (diluted) | $-9.40 | $-59.81 | $-53.15 | $-0.83 | $-0.49 |
| Operating cash flow | -$14.8M | -$30.1M | -$23.8M | -$25.1M | -$20.9M |
| Free cash flow | — | -$30.3M | -$26.7M | -$25.6M | -$22.1M |
| Cash & equivalents | $6.4M | $2.1M | $14.8M | $22.9M | $19.5M |
| Inventory | — | — | $109,798 | — | — |
| Total assets | $51.8M | $3.7M | $28.8M | $31.0M | $31.7M |
| Total liabilities | $10.7M | $16.8M | $19.8M | $13.8M | $11.2M |
| Shareholders' equity | $41.1M | -$13.1M | $9.0M | $17.2M | $20.5M |
Source: SEC EDGAR filings · CIK 0001682639 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.